bioRxivBiochemistryPreprint
Hyperactivation of β-catenin rewires mitochondrial fuel selection in liver cancer cells
Luis Cedeño-RosarioiD, Queren A. AlcantaraiD, Nicole A. SierraiD, Praveena PrasadiD, Jillian WrightiD, Geanette Lam, Nimo AbdiiD, Jaide FlorenceiD, Alex J. BottiD, Katarina E. HeydeniD, Joshua C. Youngs, Álvaro Jesús Narbona‐PéreziD, Lorenzo Gastelum MenaiD, Monika A. MakurathiD, Jesse N. Velasco‐SilvaiD, Mi-Young Jeong, Sarah FogartyiD, Gregory S. DuckeriD, Jennifer Lippincott‐SchwartziD, Melanie R. McReynoldsiD, Jared P. RutteriD
Abstract
Metabolic state is tightly linked to cell fate, and expression of the mitochondrial pyruvate carrier (MPC), which imports pyruvate into mitochondria, is a robust marker of it. The transcriptional regulators that set metabolic state, however, remain poorly defined. In the liver, {beta}-catenin is one of the determinants of metabolic zonation, and activating CTNNB1 mutations are frequent in hepatocellular carcinoma. Here we show that {beta}-catenin regulates metabolic state in liver cancer cells. An unbiased CRISPR screen that uses endogenous MPC1 transcript abundance as the marker identifies CTNNB1. Activating {beta}-catenin pharmacologically or genetically reduces MPC1 and MPC2 transcript and protein levels, and MPC expression is also low in {beta}-catenin-driven liver tumors in vivo. Beyond the MPC, {beta}-catenin activation impairs assembly of respiratory Complexes III and IV, reduces mitochondrial DNA content and respiratory capacity, elongates mitochondrial networks and remodels the lipidome. Stable isotope tracing shows reduced entry of glucose- and lactate-derived carbon into the TCA cycle alongside increased oxidation of palmitate and oleate. These findings identify {beta}-catenin as a regulator of metabolic state that drives a fuel switch from carbohydrate to fatty acid oxidation in liver cancer cells.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Phospholipid isotope tracing reveals β-catenin-driven suppression of phosphatidylcholine metabolism in hepatocellular carcinoma
C. VanSant-Webb, H. K. Low, … G. S. Ducker·bioRxiv·Oct 12, 2023
- Methionine metabolism and the NOP2 methyltransferase are essential for MYC-Driven liver tumorigenesis.
Sensen Lin, Charles A. Berdan, … Andrei Goga·bioRxiv·Jan 30, 2026
- Tumor Genotype Dictates Mitochondrial and Immune Vulnerabilities in Liver Cancer
Gökhan Ünlü, Alon Millet, … Kıvanç Birsoy·bioRxiv·Sep 10, 2025
- BACH1 promotes hepatocellular carcinoma progression by targeting PDP1 towards the PI3K-AKT-mTOR signaling activation
Qiqi Bu, Xiaojing Qi, … Yiguo Zhang·Bioorganic ChemistryPeer-reviewed·Oct 31, 2025
- HKDC1 Promotes Liver Cancer Stemness Under Hypoxia via Stabilizing β-Catenin
- BET inhibition induces GDH1-dependent glutamine metabolic remodeling and vulnerability in liver cancer